Recombinant multi-species FGF13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FGF13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked cognitive disability mapping to this region. Alternative splicing of this gene at the 5' end results in several transcript variants encoding different isoforms with different N-termini. [provided by RefSeq, Nov 2008]
The Alternative Names of target: DEE90,FGF-13,FGF13,FGF2,FHF-2,FHF2,Fgf13,Fgf1c,Fhf2,Fibroblast growth factor 13,Fibroblast growth factor homologous factor 2 (FHF-2),LINC00889,XLID110

Target products collectionGo to FGF13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6565-Ag-1/ GM-Tg-hg-IP6565-Ag-2 Human FGF13 protein Human
GM-Tg-rg-IP6565-Ag-1/ GM-Tg-rg-IP6565-Ag-2 Rat FGF13 protein Rat
GM-Tg-mg-IP6565-Ag-1/ GM-Tg-mg-IP6565-Ag-2 Mouse FGF13 protein Mouse
GM-Tg-cynog-IP6565-Ag-1/ GM-Tg-cynog-IP6565-Ag-2 Cynomolgus/Rhesus macaque FGF13 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6565-Ag-1/ GM-Tg-felg-IP6565-Ag-2 Feline FGF13 protein Feline
GM-Tg-cang-IP6565-Ag-1/ GM-Tg-cang-IP6565-Ag-2 Canine FGF13 protein Canine
GM-Tg-bovg-IP6565-Ag-1/ GM-Tg-bovg-IP6565-Ag-2 Bovine FGF13 protein Bovine
GM-Tg-equg-IP6565-Ag-1/ GM-Tg-equg-IP6565-Ag-2 Equine FGF13 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6565-Ag-1/ GM-Tg-hg-IP6565-Ag-2; GM-Tg-rg-IP6565-Ag-1/ GM-Tg-rg-IP6565-Ag-2;
GM-Tg-mg-IP6565-Ag-1/ GM-Tg-mg-IP6565-Ag-2; GM-Tg-cynog-IP6565-Ag-1/ GM-Tg-cynog-IP6565-Ag-2;
GM-Tg-felg-IP6565-Ag-1/ GM-Tg-felg-IP6565-Ag-2; GM-Tg-cang-IP6565-Ag-1/ GM-Tg-cang-IP6565-Ag-2;
GM-Tg-bovg-IP6565-Ag-1/ GM-Tg-bovg-IP6565-Ag-2; GM-Tg-equg-IP6565-Ag-1/ GM-Tg-equg-IP6565-Ag-2
Products Name FGF13 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FGF13
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FGF13 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.